Taisho Pharmaceutical
4581.TTokyo, Japan· Est.
Japanese pharmaceutical company with diversified operations in OTC self-medication products and prescription drugs focused on respiratory and metabolic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
Japanese pharmaceutical company with diversified operations in OTC self-medication products and prescription drugs focused on respiratory and metabolic diseases.
RespiratoryMetabolic
Technology Platform
Traditional small molecule drug discovery and development with focus on respiratory and metabolic disease targets.
Opportunities
Growth in Japan's aging population creates demand for chronic disease treatments in both OTC and prescription segments, while international expansion offers market diversification.
Risk Factors
Dependence on Japanese OTC market, counterfeit products damaging brand reputation, generic competition for prescription drugs, and need for pipeline innovation beyond traditional small molecules.
Competitive Landscape
Competes with major Japanese pharmaceutical companies (Daiichi Sankyo, Takeda, Eisai) in OTC and prescription markets, with differentiation through strong consumer brand recognition and established distribution networks.